Key result
Women face unique cardiovascular risks and experience poorer outcomes following coronary revascularization versus men.
Highlights the unique cardiovascular risk factors and poorer outcomes in women, emphasizing the need for tailored risk management.
May support sex-specific risk assessment in women; leaves open whether targeted interventions improve revascularization outcomes.
Heart disease is the leading cause of death in women. Unique risk factors have been recognized, including pre-eclampsia, eclampsia and autoimmune diseases. Diabetes and hypertension (HTN) also play a unique role in women. Women with diabetes have a higher risk for coronary heart disease and microvascular disease compared with males. Additionally, older women have a high prevalence of uncontrolled HTN and women tend to have more treatment resistant HTN, increasing risk for cardiovascular events and mortality. The outcomes of cardiovascular disease have shown an increase in the number of heart attacks in younger women, though there is decreasing mortality. Treatment with coronary artery bypass graft surgery and percutaneous intervention has also shown to have poorer outcomes in women.
No takes yet. Share an insight, caveat, or question.
Kurth et al. (2015) conducted a review in Cardiovascular disease. Women face unique cardiovascular risk factors, including pre-eclampsia and autoimmune diseases, and experience poorer outcomes following coronary revascularization compared with men.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: